A Multicenter Prospective Randomized Controlled Trial Comparing Cxbladder Triage to Cystoscopy in Patients With Microhematuria: The Safe Testing of Risk for Asymptomatic Microhematuria Trial.
Publication Date: 2024 Jul
Full Text Sources
Authors
Yair Lotan; Siamak Daneshmand; Neal Shore; Peter Black; Kristen R Scarpato; Amit Patel; Tony Lough; Daniel A Shoskes; Jay D RamanAbstract
OBJECTIVE
AUA guidelines for patients with microhematuria (≥3 red blood cells [RBC]/high-power field [hpf]) include cystoscopy for most over age 40 due to risk of urothelial cancer (UC). Cxbladder Triage (CxbT) is a urinary genomic test with UC negative predictive value of 99%. In this prospective randomized controlled trial, we compared cystoscopy use in a standard of care (SOC) arm vs a marker-based approach.
Source
The Journal of urology
Pub Types(s)
Journal Article
Language
English
PubMed ID
38700731